Project Grant HT94252510507
Award Date
8/1/25
Completion Date
7/31/29
Dollars Obligated
$1.2M
Federal Agency
Defense Health Agency
Awardee
Duke University (TP7EK8DZV6N5)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Durham, NC 27705, USA
Similar Awards
This Project Grant award, valued at $2,411,921.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports cognitive rehabilitation research aimed at treating anger in veterans with traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD). The project will be conducted by Duke University's Office of Research Administration Division, a leading provider of advanced medical research to federal agencies....
The University of Texas Health Science Center at San Antonio (UTHSCSA) was awarded a $1,181,251 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "COMPUTERIZED ANGER MANAGEMENT PROTOCOL (CAMP) FOR SERVICE MEMBERS WITH AND WITHOUT A HISTORY OF MILD TRAUMATIC BRAIN INJURY", will fund research to develop and evaluate a novel computerized anger management protocol for active-duty service members,...
The Department of the Army Medical Command awarded a $1,000,000 project grant to Duke University's Office of Research Administration Division under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on June 1, 2024 and running through May 31, 2027, will fund a practical multi-domain risk model of Alzheimer's disease and related dementias for veteran and non-veteran older U.S. adults. The research project aims to improve the health and care of military service...
The Defense Health Agency awarded Duke University a $402,500 Project Grant under the Military Medical Research and Development program (CFDA 12.420) for the period of June 1, 2023 through May 31, 2025. The grant will support Duke University's research efforts to target the ferropotosis protection mechanism of serum to disable cancer metastasis. The Military Medical Research and Development program aims to transform military and public health through innovative medical research solutions for both...
The Defense Health Agency awarded Duke University a $1,167,250 Project Grant (CFDA 12.420 - Military Medical Research and Development) with a performance period from June 1, 2024 to May 31, 2027. The grant funding supports Duke's research on the role of the NLRP3-NLRC5 signaling pathway in melanoma immune evasion and dormancy. The research aims to advance the understanding of mechanisms underlying melanoma progression, with the potential to inform new therapeutic approaches. As a prominent...
This $240,897 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, will support integrative transcriptomic and epigenomic profiling of subependymal giant cell astrocytoma at single-cell resolution. The award was made to Duke University's Office of Research Administration on August 1, 2025, with a period of performance through July 31, 2027. The Military Medical Research and Development program funds advanced biomedical...
The Defense Health Agency awarded Duke University a $1,086,934 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to develop a compact, autoaligning multimodality eye imager to diagnose traumatic eye injuries. The award period runs from August 15, 2024 to August 14, 2027. Through this federal grant, Duke University will conduct research and development to create an advanced medical device that can accurately assess and diagnose traumatic eye conditions,...
The Defense Health Agency awarded Duke University a $759,627.49 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "ACCELERATED AGING IN GULF WAR ILLNESS: PHENOTYPES, EPIGENETIC BIOMARKERS, AND ASSOCIATIONS WITH GULF WAR EXPOSURES." The project will run from August 1, 2023 to July 31, 2026. Duke University, a top-ranked global research institution, will be the prime awardee and perform the research through its Office of...
The Department of Defense's Defense Health Agency awarded a $700,032 Project Grant to Duke University under the Military Medical Research and Development (CFDA 12.420) program. The grant, effective August 1, 2025 through July 31, 2029, will fund research to investigate "Imaging Strategies and Biomarkers for Detecting the Metabolic Interplay of Glutamine and Aspartate in RCC." This research aims to transform healthcare for military service members, veterans, and the broader public by...
Duke University was awarded a $1,444,257 project grant from the Department of the Army Medical Command through its Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2021 through September 2025 to develop new approaches for preventing chronic pain and neuroinflammation resulting from traumatic brain injury. Specifically, the grant supports investigation of neuroprotectin D1 and GPR37 signaling to transform treatment for service members...